Abstract
Picibanil (OK432), an extract from streptococci, has been widely utilized to treat malignant ascites and pleural effusions. The antitumor mechanism is believed to include complement-mediated neutrophil activation. Employing a flow-cytometric analysis of actin polymerization as an indicator of cell activation as well as a tumor proliferation assay, we have found that monocytederived neutrophil-activating factors were involved in OK432-induced neutrophil activation as well as antitumor activity. OK432-stimulated (0.1 KE/ml; 0.01 mg/ml) monocyte supernatants (OKMS) induced neutrophil actin polymerization and chemotaxis. OKMS were responsible for neutrophil-mediated inhibition of human leukemic (CEM) cell proliferation and stimulated neutrophils to produce superoxide in the presence of CEM leukemic cells at an effector/target ratio higher than 20/1. In contrast, OK432 alone, OK432-stimulated lymphocyte supernatants, or OK432-stimulated neutrophil supernatants had no effect on neutrophil activation or suppression of tumor cell proliferation. OK432 in combination with mononuclear cells also had no effect on the inhibition of CEM cell proliferation. Pretreatment of OKMS at 56°C for 30 min did not affect its ability to activate neutrophils, implying that complement activation is not responsible for the neutrophil activation. Supernatants from OK432-stimulated mononuclear cells, as determined by enzyme-linked immunosorbent assays and radioimmunoassays, contained high levels of interleukin-8 (IL-8; 1567±145 pg/ml) and tumor necrosis factor (TNFα; 2105±152 pg/ml), low levels of leukotriene B4 (800±45 pg/ml) and IL-1β (180±22 pg/ml), but interferon γ was not detectable. IL-1β, IL-8, and TNFα transcripts, undetectable in untreated monocytes, increased significantly after 30–60 min exposure to OK432. These results suggest that neutrophil-activating factors from monocytes or resident macrophages may play an important role in the OK432-induced neutrophil activation and antitumor activity.
Key words: OK432, Neutrophil, Antitumor activity
References
- 1.Barak LS, Yocum RR. Nitrobenzooxadiazole phallacidin: synthesis of a fluorescent actin probe. Anal Biochem. 1981;110:31. doi: 10.1016/0003-2697(81)90107-x. [DOI] [PubMed] [Google Scholar]
- 2.Barak LS, Yocum RR, Nothnagel E, Webb N. Fluorescence staining of the actin cytoskeleton in living cells with 7-nitrobenzo-2-oxa-1,3-diazole phallacidin. Proc Natl Acad Sci USA. 1980;77:980. doi: 10.1073/pnas.77.2.980. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Bray D, Thomas C. The actin content of fibroblasts. Biochem J. 1975;147:221. doi: 10.1042/bj1470221. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Casella JF, Flanagan M, Lin S. Cytochalesin D inhibits actin polymerization and induces depolymerization of actin filaments formed during platelet shape change. Nature. 1981;293:302. doi: 10.1038/293302a0. [DOI] [PubMed] [Google Scholar]
- 5.Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 1979;18:5294. doi: 10.1021/bi00591a005. [DOI] [PubMed] [Google Scholar]
- 6.Clark RA, Klebanoff SJ. Studies on the mechanism of antibody-dependent polymorphonuclear leukocyte-mediated cytotoxicity. J Immunol. 1977;119:1413. [PubMed] [Google Scholar]
- 7.Cleveland DW, Lopata MA, MacDonald RJ, Cowan NJ, Rutter NJ, Kirschner MW. Number and evolutionary conservation of an alpha- and beta-tubulin and cytoplasmic beta- and gamma-actin gene using specific cloned cDNA probes. Cell. 1980;20:95. doi: 10.1016/0092-8674(80)90238-x. [DOI] [PubMed] [Google Scholar]
- 8.Fujimura T, Torisu M. Neutrophil-mediated tumor cell destruction in cancer ascites: II. A OK-432 attracts killer neutrophils through activation of complement C5. Clin Immunol Immunopathol. 1987;43:174. doi: 10.1016/0090-1229(87)90125-5. [DOI] [PubMed] [Google Scholar]
- 9.Gerrard TL, Cohen DJ, Kaplan AM. Human neutrophil-mediated cytotoxicity to tumor cells. J Natl Cancer Inst. 1981;66:483. [PubMed] [Google Scholar]
- 10.Hayashi Y, Torisu M. New approach to management of malignant ascites with streptococcal preparation OK-432: III. OK-432 attracts natural killer cells through a chemotactic factor released from activated neutrophils. Surgery. 1990;107:74. [PubMed] [Google Scholar]
- 11.Hill HR. Laboratory aspects of immune deficiency in children. Pediatr Clin North Am. 1980;27:805. doi: 10.1016/s0031-3955(16)33927-x. [DOI] [PubMed] [Google Scholar]
- 12.Howard TH, Meyer WH. Chemotactic peptide modulation of actin assembly and locomotion in neutrophils. J Cell Biol. 1984;98:1265. doi: 10.1083/jcb.98.4.1265. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Hudson L, Hay FC. Practical immunology. 3rd edn. Oxford: Blackwell; 1989. Immunological techniques in clinical medicine; p. 442. [Google Scholar]
- 14.Katano M, Torisu M. Neutrophil-mediated tumor cell destruction in cancer ascites. Cancer. 1982;50:62. doi: 10.1002/1097-0142(19820701)50:1<62::aid-cncr2820500113>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
- 15.Katano M, Torisu M. New approach to management of malignant ascites with a streptococcal preparation, OK432: II. Intraperitoneal inflammatory cell-mediated tumor cell destruction. Surgery. 1983;93:365. [PubMed] [Google Scholar]
- 16.Kato H, Yamamura Y, Kin R, Tanigawa M, Sano H, Inoue M, Sugino S, Kondo M. Treatment of malignant ascites and pleurisy by a streptococcal preparation OK432 with fresh frozen plasma: a mechanism of polymorphonuclear leukocytes (PMNs) accumulation. Int J Immunopharmacol. 1989;11:117. doi: 10.1016/0192-0561(89)90063-5. [DOI] [PubMed] [Google Scholar]
- 17.Kato H, Inoue M, Yamamura Y, Tanigawa M, Sano H, Sugino S, Kondo M. Mechanism of polymorphonuclear leukocytes accumulation examined using inhibitors of complement and arachidonic acid cascade in rats treated with OK-432. Nat Immun Cell Growth Regul. 1989;8:290. [PubMed] [Google Scholar]
- 18.Korn ED. Actin polymerization and its regulation by proteins from nonmuscle cells. Physiol Rev. 1983;62:672. doi: 10.1152/physrev.1982.62.2.672. [DOI] [PubMed] [Google Scholar]
- 19.Matsumura I, Kiso S, Tago H, Kawakami F, Fushimi H, Aozasa K, Kanakura Y, Tamaki T, Kanayama Y, Yoonezawa T. Adult T cell leukemia/lymphoma with hyperprolactinemia: successful treatment by OK432 and PSK (English abstract) Rinsho Ketsueki. 1991;32:266. [PubMed] [Google Scholar]
- 20.Matsushima K, Morishita K, Yoshimura T, Lavu S, Kobayashi Y, Lew W, Appella E, Kung HK, Leonard EJ, Oppenheim JJ. Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor. J Exp Med. 1988;167:1883. doi: 10.1084/jem.167.6.1883. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Packman CH, Lichtman MA. Activation of neutrophils: measurement of actin conformational changes by flow cytometry. Blood Cells. 1990;16:193. [PubMed] [Google Scholar]
- 22.Rao KMK, Varani J. Actin polymerization induced by chemotactic peptides and concanavalin A in rat neutrophils. J Immunol. 1982;129:1605. [PubMed] [Google Scholar]
- 23.Saji S, Umemoto T, Tachibana S, Takao H, Sakata K. Antitumor effects of neutrophils induced by local administration of a nonspecific immunopotentiator, OK432: clinical and experimental studies. In: Ishida N, editor. Mechanisms of antitumor effects of OK432. Tokyo: Excerpta Medica; 1986. p. 34. [Google Scholar]
- 24.Souza GE, Cunha FQ, Mello R, Ferreira SH. Neutrophil migration induced by inflammatory stimuli is reduced by macrophage depletion. Agents Actions. 1988;24:377. doi: 10.1007/BF02028296. [DOI] [PubMed] [Google Scholar]
- 25.Stone RM, Imamura K, Datta R, Sherman ML, Kufe DW. Inhibition of phorbol ester-induced monocytic differentiation and c-fms gene expression by dexamethasone: potential involvement of arachidonic acid metabolites. Blood. 1990;76:1225. [PubMed] [Google Scholar]
- 26.Standiford TJ, Strieter RM, Chensue SW, Westwick J, Kasahara K, Kunkel SL. IL-4 inhibits the expression of IL-8 from stimulated human monocytes. J Immunol. 1990;145:1435. [PubMed] [Google Scholar]
- 27.Strieter RM, Chensue SW, Basha MA, Standiford TJ, Lynch JP, III, Baggiolini M, Kunkel SL. Human aveolar macrophage gene expression of interleukin-8 by TNFα and IL-1β. Am J Respir Cell Mol Biol. 1990;2:321. doi: 10.1165/ajrcmb/2.4.321. [DOI] [PubMed] [Google Scholar]
- 28.Torisu M, Katano M, Kimura Y, Itoh H, Takesue M. New approach to management of malignant ascites with a streptococcal preparation, OK432: I. Improvement of host immunity and prolongation of survival. Surgery. 1983;93:357. [PubMed] [Google Scholar]
- 29.Wallace PJ, Wersto RP, Packman CH, Lichtman MA. Chemotactic peptide-induced changes in neutrophil actin conformation. J Cell Biol. 1984;99:1060. doi: 10.1083/jcb.99.3.1060. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Wang AM, Creasey AA, Ladner MB, Lin LS, Stricker J, van Arsdell JN, Yamamoto R, Mark DF. Molecular cloning of the complementary DNA for human tumor necrosis factor. Science. 1985;228:149. doi: 10.1126/science.3856324. [DOI] [PubMed] [Google Scholar]
- 31.Watabe S, Sendo F, Kimura S, Arai S. Activation of cytotoxic polymorphonuclear leukocytes by in vivo administration of a streptococcal preparation, OK432. J Natl Cancer Inst. 1984;72:1365. [PubMed] [Google Scholar]
- 32.Yang KD, Augustine NH, Gonzalez LA, Bohnsack JF, Hill HR. Effects of fibronectin on the interaction of polymorphonuclear leukocytes with unopsonized and antibody-opsonized bacteria. J Infect Dis. 1988;158:823. doi: 10.1093/infdis/158.4.823. [DOI] [PubMed] [Google Scholar]
- 33.Yang KD, Bohnsack JF, Hawley MW, Egan ML, Pritchard DG, Hill HR. Effect of fibronectin on IgA-mediated uptake of type III group B streptococci by phagocytes. J Infect Dis. 1990;161:236. doi: 10.1093/infdis/161.2.236. [DOI] [PubMed] [Google Scholar]